PHASE-II CLINICAL-TRIAL OF CISPLATIN (CDDP), 5-FLUOROURACIL (5-FU) AND IFOSFAMIDE (IFX) AS TREATMENT FOR ADVANCED LOCOREGIONAL HEAD AND NECK-CARCINOMA (AHNC)
Ms. Parra et al., PHASE-II CLINICAL-TRIAL OF CISPLATIN (CDDP), 5-FLUOROURACIL (5-FU) AND IFOSFAMIDE (IFX) AS TREATMENT FOR ADVANCED LOCOREGIONAL HEAD AND NECK-CARCINOMA (AHNC), Annals of oncology, 9, 1998, pp. 380-380